Press "Enter" to skip to content

Ekol Hospitals Leads the Way in Personalised Obesity Treatment

BALANCING NEW MEDICATIONS WITH TAILORED CARE PLANS FOR LASTING RESULTS

As the global healthcare community turns its attention to the recent approval of Mounjaro (tirzepatide) for weight management in the UK, Ekol International Hospitals in Izmir, Turkey, stresses that medication alone cannot solve the complex obesity crisis. Instead, they advocate for an integrated approach, combining advanced surgical procedures, lifestyle coaching, and emotional well-being support.

At Ekol Hospitals, patient care goes beyond the operating room. Their philosophy centers on understanding the individual behind the diagnosis. “Each case of obesity is unique, shaped by a variety of factors including genetics, environment, and lifestyle,” notes Prof. Dr. Ömer Yoldaş, a leading bariatric surgeon at the institution. Recognising the limitations of pharmacological solutions, Ekol’s team has developed a comprehensive care model that blends medical innovation with personal support.

Assoc. Prof. Dr. Ömer Yoldaş – Photo: Ekol International Hospitals

Surgical options such as gastric bypass and sleeve gastrectomy are carefully recommended as part of a broader, long-term care strategy that includes mental health counselling and nutritional advice. Ekol’s holistic framework has already improved the lives of thousands, proving that sustainable health outcomes require more than medication.

Photo: Ekol Hospitals

With a rising global prevalence of obesity, experts at Ekol highlight the importance of creating a supportive environment where individuals feel empowered rather than judged. They call on the international healthcare community to adopt a similar multidimensional strategy to achieve lasting progress.